Fargon N.V.

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

5.82%

Market Cap

1.73 Bil.

P/E Ratio

17.10

Dividend Yield

1.31 %

Earnings per Share

1.25 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE23.85 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 07:32:02 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW23.8523.5
PREV. DAY'S PRICE23.65 (07/20)
CHANGE DAY BEFORE
+0.20
0.85 %
52 WEEK HIGH / LOW25.4 (05/25)19.32 (09/25)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.971.101.251.391.59
DIVIDENDS PER SHARE
0.210.250.280.420.44
DIVIDEND YIELD IN %
1.26 %1.46 %1.31 %--
DIVIDEND GROWTH IN %
20.00 %16.67 %14.29 %--
PRICE - EARNINGS RATIO
17.1915.1817.1017.1514.98
PRICE - BOOK RATIO
2.612.432.83--
PRICE - SALES RATIO
1.591.401.64--
PRICE - CASH FLOW RATIO
11.2914.6412.15--
Further Key Figures

Master Data

WKN
A0M103
ISIN
BE0003874915
SYMBOL
4A5
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Arseus
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
73.35 Mil.
MARKET CAPITALISATION
1.73 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-0.84 %
-1.87 %
-2.87 %
4.88 %
5.82 %
47.35 %
37.26 %
11.82 %
HIGH24.1524.6025.4025.4025.4025.4025.4025.40
LOW23.5023.4522.9520.9519.3215.5710.9720.95

Dividende

pro Aktie

Company profile

Fagron NV engages in the development, marketing, and distribution of healthcare products and services. It operates through the following segments: Essentials, Brands, and Compounding Services. The Essential segment focuses on supplying raw materials to community and hospital pharmacies for pharmaceutical compounding. The Brands segment is involved in developing and producing semi-finished products and vehicles, such as emulsions, powder mixtures, creams, and other excipients, as well as total concepts and equipment for pharmaceutical compounding. The Compounding Services segment offers community and hospital pharmacies with ready-to-use non-sterile compounded medicine in those countries where it is permitted. The company was founded in 1990 and is headquartered in Nazareth, Belgium.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.